Multiple randomized trials, as well as a meta-analysis support the ability of platinum-based chemotherapy to prolong survival compared to best supportive care in advanced disease patients.
多个随机研究及meta-分析证明以铂类为基础的化疗与最佳支持治疗相比可延长晚期患者的生存期。
Conclusion:Early diagnosis and surgical radical cystoprostatectomy are mandatory to prolong survival.
结论:早期诊断并行根治性手术可提高患者的生存率。
Palliative operation and surgery for perforated gastric carcinoma will prolong survival period of the patient with AGC.
姑息性胃癌切除术和胃癌穿孔的积极手术治疗,可以延长患者的生存期。
Objective: To prolong survival time of the isolated rabbit heart by improving perfusion experiment for isolated rabbit hearts.
目的:通过改进离体心脏灌流试验,延长家兔离体心脏存活时间。
Conclusions MVP chemotherapy combined with radiotherapy can improve survival quality, prolong survival time, improve survival rate of advanced lung adenocarcinoma.
结论MVP化疗联合放疗能改善晚期肺腺癌患者生存质量,延长生存期,提高生存率。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗,可以改善临床症状、延长存活期。
Conclusion Double intubated hepatic artery and portal vein regional infusion chemotherapy in non-resectable metaphase or late primary liver carcinoma may ameliorate symptoms and prolong survival time.
结论中晚期不能切除的原发性肝癌使用肝动脉、门静脉双重插管灌注化疗,可以改善临床症状、延长存活期。
应用推荐